“It is our great privilege to welcome Gil Omenn to the FNIH Board of Directors,” said Steven M. Paul, M.D., Chairman of the FNIH Board. “His unparalleled expertise and accomplishments in medicine, genetics and public health span decades and demonstrate a life-long commitment to improving human health via biomedical research carried out at the highest level. We are thrilled that Gil will now help the FNIH in its mission to support NIH.”
Dr. Omenn is the Harold T. Shapiro Distinguished University Professor of Computational Medicine & Bioinformatics, Internal Medicine, Human Genetics and Public Health and founding director of the Center for Computational Medicine & Bioinformatics at the University of Michigan in Ann Arbor. He previously served as a Howard Hughes Medical Institute investigator and Dean of the School of Public Health & Community Medicine at the University of Washington, then Executive Vice-President for Medical Affairs and CEO of the Health System at the University of Michigan. He is an elected member of the National Academy of Medicine, the Association of American Physicians and the American Academy of Arts and Sciences and a fellow of the American College of Physicians, the National Academy for Social Insurance and the American Association for the Advancement of Science. Dr. Omenn earned a B.A. from Princeton, an M.D. from Harvard and a Ph.D. in genetics from the University of Washington.
“The NIH has been very important in my career. I am delighted to join the Board of the FNIH,” said Dr. Omenn. “I am eager to help the FNIH build ever-stronger alliances that enhance the mission of our nation’s preeminent health research agency, particularly in this challenging time.”
For more information about the FNIH Board of Directors, please visit fnih.org/about/directors.
###
About the Foundation for the National Institutes of Health
The Foundation for the National Institutes of Health creates and manages alliances with public and private institutions in support of the mission of the NIH, the world’s premier medical research agency. The Foundation, also known as the FNIH, works with its partners to accelerate biomedical research and strategies against diseases and health concerns in the United States and across the globe. The FNIH organizes and administers research projects; supports education and training of new researchers; organizes educational events and symposia; and administers a series of funds supporting a wide range of health issues. Established by Congress in 1990, the FNIH is a not-for-profit 501(c)(3) charitable organization. For additional information about the FNIH, please visit fnih.org.